Cargando…
Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years
Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the ef...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896221/ https://www.ncbi.nlm.nih.gov/pubmed/35250598 http://dx.doi.org/10.3389/fphar.2022.846715 |
_version_ | 1784663113068445696 |
---|---|
author | Hao, Xinyan Wu, Junyong Xiang, DaXiong Yang, Yongyu |
author_facet | Hao, Xinyan Wu, Junyong Xiang, DaXiong Yang, Yongyu |
author_sort | Hao, Xinyan |
collection | PubMed |
description | Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the efficiency of tumor therapies and significantly prolonged the survival period, whether for traditional tumor treatment methods such as radiotherapy, or emerging methods, such as phototherapy and immunotherapy, sonodynamic therapy, chemodynamic therapy and RNA interference therapeutics. Various monotherapies have obtained positive results, while combination therapies are further proposed to prevent incomplete eradication and recurrence of tumors, strengthen tumor killing efficacy with minimal side effects. In view of the complementary promotion effects between different therapies, it is vital to utilize nanomaterials as the link between monotherapies to achieve synergistic performance. Further development of nanomaterials with efficient tumor-killing effect and better biosafety is more in line with the needs of clinical treatment. In a word, the development of nanomaterials provides a promising way for tumor treatment, and here we will review the emerging nanomaterials towards radiotherapy, phototherapy and immunotherapy, and summarized the developed nanocarriers applied for the tumor combination therapies in the past 5 years, besides, the advances of some other novel therapies such as sonodynamic therapy, chemodynamic therapy, and RNA interference therapeutics have also been mentioned. |
format | Online Article Text |
id | pubmed-8896221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88962212022-03-05 Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years Hao, Xinyan Wu, Junyong Xiang, DaXiong Yang, Yongyu Front Pharmacol Pharmacology Cancer has posed a major threat to human life and health with a rapidly increasing number of patients. The complexity and refractory of tumors have brought great challenges to tumor treatment. In recent years, nanomaterials and nanotechnology have attracted more attention and greatly improved the efficiency of tumor therapies and significantly prolonged the survival period, whether for traditional tumor treatment methods such as radiotherapy, or emerging methods, such as phototherapy and immunotherapy, sonodynamic therapy, chemodynamic therapy and RNA interference therapeutics. Various monotherapies have obtained positive results, while combination therapies are further proposed to prevent incomplete eradication and recurrence of tumors, strengthen tumor killing efficacy with minimal side effects. In view of the complementary promotion effects between different therapies, it is vital to utilize nanomaterials as the link between monotherapies to achieve synergistic performance. Further development of nanomaterials with efficient tumor-killing effect and better biosafety is more in line with the needs of clinical treatment. In a word, the development of nanomaterials provides a promising way for tumor treatment, and here we will review the emerging nanomaterials towards radiotherapy, phototherapy and immunotherapy, and summarized the developed nanocarriers applied for the tumor combination therapies in the past 5 years, besides, the advances of some other novel therapies such as sonodynamic therapy, chemodynamic therapy, and RNA interference therapeutics have also been mentioned. Frontiers Media S.A. 2022-02-18 /pmc/articles/PMC8896221/ /pubmed/35250598 http://dx.doi.org/10.3389/fphar.2022.846715 Text en Copyright © 2022 Hao, Wu, Xiang and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Hao, Xinyan Wu, Junyong Xiang, DaXiong Yang, Yongyu Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title | Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title_full | Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title_fullStr | Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title_full_unstemmed | Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title_short | Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years |
title_sort | recent advance of nanomaterial-mediated tumor therapies in the past five years |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896221/ https://www.ncbi.nlm.nih.gov/pubmed/35250598 http://dx.doi.org/10.3389/fphar.2022.846715 |
work_keys_str_mv | AT haoxinyan recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears AT wujunyong recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears AT xiangdaxiong recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears AT yangyongyu recentadvanceofnanomaterialmediatedtumortherapiesinthepastfiveyears |